1. Home
  2. CNTB vs YAAS Comparison

CNTB vs YAAS Comparison

Compare CNTB & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • YAAS
  • Stock Information
  • Founded
  • CNTB 2012
  • YAAS 2018
  • Country
  • CNTB United States
  • YAAS China
  • Employees
  • CNTB N/A
  • YAAS N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • YAAS Computer Software: Prepackaged Software
  • Sector
  • CNTB Health Care
  • YAAS Technology
  • Exchange
  • CNTB Nasdaq
  • YAAS Nasdaq
  • Market Cap
  • CNTB 54.4M
  • YAAS 59.0M
  • IPO Year
  • CNTB 2021
  • YAAS 2024
  • Fundamental
  • Price
  • CNTB $2.00
  • YAAS $0.38
  • Analyst Decision
  • CNTB Strong Buy
  • YAAS
  • Analyst Count
  • CNTB 2
  • YAAS 0
  • Target Price
  • CNTB $7.50
  • YAAS N/A
  • AVG Volume (30 Days)
  • CNTB 280.7K
  • YAAS 3.1M
  • Earning Date
  • CNTB 09-04-2025
  • YAAS 07-14-2025
  • Dividend Yield
  • CNTB N/A
  • YAAS N/A
  • EPS Growth
  • CNTB N/A
  • YAAS N/A
  • EPS
  • CNTB N/A
  • YAAS N/A
  • Revenue
  • CNTB $26,033,000.00
  • YAAS $581,862.00
  • Revenue This Year
  • CNTB N/A
  • YAAS N/A
  • Revenue Next Year
  • CNTB N/A
  • YAAS N/A
  • P/E Ratio
  • CNTB N/A
  • YAAS N/A
  • Revenue Growth
  • CNTB N/A
  • YAAS N/A
  • 52 Week Low
  • CNTB $0.51
  • YAAS $0.36
  • 52 Week High
  • CNTB $2.86
  • YAAS $7.00
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 59.15
  • YAAS N/A
  • Support Level
  • CNTB $1.70
  • YAAS N/A
  • Resistance Level
  • CNTB $2.45
  • YAAS N/A
  • Average True Range (ATR)
  • CNTB 0.36
  • YAAS 0.00
  • MACD
  • CNTB -0.02
  • YAAS 0.00
  • Stochastic Oscillator
  • CNTB 42.51
  • YAAS 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About YAAS Youxin Technology Ltd Class A Ordinary shares

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: